Newsfeeds Archive - Page 399 of 461

1 minute read

Immunovant’s New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say

September 29, 2:36 PM

On Wednesday, Immunovant Inc (NASDAQ:IMVT) announced a new anti-FcRn, IMVT-1402, at Roivant Sciences Ltd’s (NASDAQ:ROIV) Investor Day. IMVT-1402 is a new anti-FcRn monoclonal antibody…

ARGX

1 minute read

SIGA Technologies Bags New DoD Contract For Monkeypox Treatment

By Vandana Singh

September 29, 1:35 PM

SIGA Technologies Inc (NASDAQ:SIGA) announced that the U.S. Department of Defense (DoD) awarded a new contract to the company…

SIGA

1 minute read

Novo Nordisk Joins NLRP3 Bandwagon, Bets $70M On Ventus’ Lead Drug Candidate

By Vandana Singh

September 29, 12:49 PM

Biotechnology startup Ventus Therapeutics is licensing its lead research program, a drug candidate for inflammatory disorders, to Novo Nordisk A/S (NYSE:NVO) for…

NVO

1 minute read

Biohaven’s ALS Drug Fails To Meet Study Endpoint, Second Therapy To Fail Trials In Recent Months

By Vandana Singh

September 29, 12:24 PM

Biohaven Pharmaceutical Holding Company Ltd (NASDAQ: BHVN) announced results from a focused analysis of verdiperstat in the HEALEY ALS Platform Trial in amyotrophic lateral sclerosis (ALS).

BHVN

1 minute read

Silence Therapeutics’ Thalassemia Hopeful Shows Favorable Safety Profile In Early Stage Study

By Vandana Singh

September 29, 11:25 AM

Silence Therapeutics plc (NASDAQ:SLN) announced preliminary results from the single dose component of the GEMINI II phase 1 study of SLN124…

SLN

1 minute read

Galecto’s Myelofibrosis Candidate Reduces Bone Marrow Fibrosis

By Vandana Singh

September 29, 11:17 AM

Galecto Inc (NASDAQ:GLTO) announced results from a planned intermediate assessment of its ongoing MYLOX-1 Phase 2a trial of GB2064 for myelofibrosis.…

GLTO

1 minute read

Regeneron-Sanofi’s Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis

By Vandana Singh

September 29, 9:54 AM

The FDA approved Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA’s (NASDAQ:SNY) Dupixent (dupilumab) for the treatment of adult patients with prurigo nodularis. With…

REGN

1 minute read

Idera Pharma Acquires Rare Disease Player, Names New CEO

By Vandana Singh

September 29, 9:52 AM

Idera Pharmaceuticals Inc (NASDAQ: IDRA) acquired Aceragen Inc, a privately-held biotechnology company focused on rare, orphan pulmonary, and rheumatic diseases.

IDRA

1 minute read

Aligos Co-Founders File Complaint Against Johnson & Johnson Alleging Fraud

By Vandana Singh

September 29, 8:40 AM

Aligos Therapeutics Inc (NASDAQ:ALGS) has filed a response to the complaint of and counterclaims against Janssen Biopharma. In November 2014, Johnson…

ALGS

1 minute read

Atara Biotherapeutics to Receive Additional Near-Term Milestone Under Updated Tab-cel Commercialization Pact

By Vandana Singh

September 29, 7:30 AM

Atara Biotherapeutics Inc (NASDAQ:ATRA) announced an update to its existing collaboration agreement with Pierre Fabre for the commercialization of tabelecleucel (tab-cel) for Epstein-Barr…

ATRA